TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.
ResMed Inc., a company involved in the healthcare sector, focuses on providing innovative solutions for sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. The recent announcement highlights a change in the company’s board, as Richard Sulpizio has ceased to serve as a director following the 2025 annual meeting of stockholders. This change in leadership may impact the company’s strategic direction and governance.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
For detailed information about RMD stock, go to TipRanks’ Stock Analysis page.